Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,385,861 | 1,582,446 | 1,526,606 | 1,945,173 | 2,121,278 |
| Receivables | 194,533 | 478,156 | 454,993 | 109,961 | 71,363 |
| Inventories | 256,301 | 106,648 | 8,872 | N/A | N/A |
| TOTAL | $2,136,002 | $2,347,405 | $2,155,119 | $2,174,181 | $2,354,992 |
| Non-Current Assets | |||||
| PPE Net | 254,526 | 247,213 | 225,741 | 214,751 | 213,186 |
| Intangibles | 127,500 | 135,291 | 131,479 | 137,016 | 139,575 |
| Other Non-Current Assets | 104,965 | 104,966 | 64,414 | 39,993 | 41,834 |
| TOTAL | $486,991 | $487,470 | $421,634 | $391,760 | $394,595 |
| Total Assets | $2,622,993 | $2,834,875 | $2,576,753 | $2,565,941 | $2,749,587 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 386,488 | 135,128 | 127,050 | 59,564 | 73,995 |
| Accrued Expenses | 585,646 | 559,876 | 673,731 | 323,867 | 249,178 |
| Other current liabilities | 34,158 | 31,271 | 36,061 | 3,637 | 9,887 |
| TOTAL | $2,156,239 | $2,261,005 | $2,390,319 | $1,753,415 | $1,651,516 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 701,518 | 1,094,232 | 1,422,944 | 1,262,360 | 1,220,073 |
| Other Non-Current Liabilities | 69,075 | 66,798 | 365,579 | 351,190 | 343,316 |
| TOTAL | $883,704 | $508,546 | $538,107 | $351,190 | $352,509 |
| Total Liabilities | $3,039,943 | $2,769,551 | $2,928,426 | $2,104,605 | $2,004,025 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 78,215 | 78,135 | 76,283 | 75,608 | 74,484 |
| Common Shares | 788 | 787 | 764 | 760 | 747 |
| Retained earnings | -3,925,027 | -3,414,542 | -3,617,950 | -2,771,666 | -2,449,235 |
| Other shareholders' equity | -11,325 | -1,213 | -1,454 | 729 | 3,965 |
| TOTAL | $-416,950 | $65,324 | $-351,673 | $461,336 | $745,562 |
| Total Liabilities And Equity | $2,622,993 | $2,834,875 | $2,576,753 | $2,565,941 | $2,749,587 |